Status:
COMPLETED
Cayenne Pepper Cataplasm - Safety Study
Lead Sponsor:
University of Primorska
Collaborating Sponsors:
S2P, Science to Practice, Ltd.
Comenius University
Conditions:
Low Back Pain
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
The beneficial analgesic effects of Rubefacenciae (redden skin substances), is known since 1830 as a treatment for pain, cramps, and disorders of the musculoskeletal system. Herbal cataplasms containi...
Detailed Description
Musculoskeletal diseases, such as neck and low back pain, are widespread disorders in many developed countries. Their management is challenging, and it may have mounting socioeconomic burden. Several ...
Eligibility Criteria
Inclusion
- Chronic low back pain (\>3 months)
- Body mass index below 35 kg/mˇ2
Exclusion
- pregnancy
- sensibility disorders (e.g. due to neurological disease)
- injuries, open wounds or rash in intervention area
- known hypersensitivity against the applied substances
- HIV, Hepatitis C and other due blood communicable infectious diseases
Key Trial Info
Start Date :
March 15 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 15 2016
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03440125
Start Date
March 15 2016
End Date
December 15 2016
Last Update
February 20 2018
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Facultiy of Physical Education and Sports, Comenius University of Bratislava
Bratislava, Slovakia, 81806
2
Faculty of Health Sciences
Izola, Slovenia, 6310